UBS AM’s Organogenesis Holdings ORGO Stock Holding History

UBS AM’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-593	Closed	-$3.07K	–	3845
2025 Q4	$3.07K	Buy	+593	New	+$2.87K	﹤0.01%	3070
2023 Q3	–	Sell	-98,659	Closed	-$210K	–	2660
2023 Q2	$210K	Hold	98,659	–	–	﹤0.01%	2559
2023 Q1	$210K	Buy	98,659 +18,044	+22%	+$44.6K	﹤0.01%	2559
2022 Q4	$217K	Hold	80,615	–	–	﹤0.01%	2424
2022 Q3	$261K	Hold	80,615	–	–	﹤0.01%	2529
2022 Q2	$393K	Buy	80,615 +42,875	+114%	+$264K	﹤0.01%	2385
2022 Q1	$288K	Hold	37,740	–	–	﹤0.01%	2607
2021 Q4	$349K	Hold	37,740	–	–	﹤0.01%	2648
2021 Q3	$537K	Hold	37,740	–	–	﹤0.01%	2475
2021 Q2	$627K	Buy	+37,740	New	+$703K	﹤0.01%	2444

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS AM's ORGO Position: Q1 2026 in Review

UBS AM sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 593 shares — an estimated $3.07K sold.

UBS AM first reported a position in ORGO in Q2 2021 and held it in 10 quarters. The position peaked at $627K in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

UBS AM reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
UBS AM sold 593 Organogenesis Holdings shares in Q1 2026, an estimated $3.07K.
UBS AM first reported a position in Organogenesis Holdings in Q2 2021 and held it in 10 quarters.
UBS AM's Organogenesis Holdings position peaked at $627K in Q2 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.